Copper Deficiency Causes and Risk Factors

Gastrointestinal Malabsorption

Inflammatory bowel disease, such as Crohn's disease and ulcerative colitis, causes copper deficiency through chronic mucosal inflammation, malabsorption, anatomic changes affecting absorptive capacity, and increased gastrointestinal losses in patients with enterocutaneous fistulae or enterostomies 1, 2
Patients with enterocutaneous fistulae or enterostomies experience ongoing copper losses that exceed normal dietary intake 3, 4

Zinc supplementation exceeding 30 mg daily is a critical cause of copper deficiency because zinc and copper compete for the same intestinal absorption pathways 3, 4, 5
The optimal zinc-to-copper ratio is 8:1 to 15:1; ratios exceeding this range precipitate copper deficiency 5
Chronic zinc toxicity is treated with copper sulfate specifically because of this competitive relationship 3, 4
Always measure both zinc and copper levels simultaneously before initiating supplementation of either mineral 5

Prolonged total parenteral nutrition without copper supplementation or with inadequate copper content causes deficiency within months 3, 4
Patients on long-term complete enteral nutrition, particularly those with jejunostomy tubes, develop copper deficiency from inadequate provision 3, 4, 5
Patients on parenteral nutrition require copper monitoring every 6-12 months 6, 5, 7

Patients with enterostomies, enterocutaneous fistulae, or chronic diarrhea lose copper through gastrointestinal secretions at rates exceeding normal dietary replacement 3, 4
Inflammatory bowel disease with active inflammation increases both mucosal losses and systemic requirements 1, 2
Prolonged renal replacement therapy (hemodialysis >2 weeks) removes copper through dialysate 3, 4, 5
Hypercatabolic states including burns, trauma, and sepsis increase urinary copper losses 3, 4
Alcoholism and diabetes mellitus increase renal copper excretion 3, 4

Sulfasalazine use in inflammatory bowel disease patients creates specific risk for micronutrient deficiencies including copper 1, 2
Multiple medications increase urinary copper losses, though specific agents are not consistently identified across guidelines 3, 4

Post-bariatric surgery patients require copper level monitoring every 6-12 months indefinitely because neurological manifestations may be irreversible if treatment is delayed 5
Patients with inflammatory bowel disease, particularly those with small bowel involvement, fistulae, or ostomies 1, 2
Patients on long-term parenteral or enteral nutrition 6, 5
Major burn patients and those on continuous renal replacement therapy exceeding 2 weeks 5
Patients taking high-dose zinc supplements (>30 mg daily) 5